These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10217112)

  • 1. Statins and C-reactive protein.
    Kluft C; de Maat MP; Gevers Leuven JA; Potter van Loon BJ; Mohrschladt MF
    Lancet; 1999 Apr; 353(9160):1274. PubMed ID: 10217112
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of simvastatin and pravastatin on hyperlipidemia and cyclosporin blood levels in renal transplant recipients.
    Capone D; Stanziale P; Gentile A; Imperatore P; Pellegrino T; Basile V
    Am J Nephrol; 1999; 19(3):411-5. PubMed ID: 10393380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.
    Farnier M; Retterstøl K; Steinmetz A; Császár A
    Diab Vasc Dis Res; 2012 Jul; 9(3):205-15. PubMed ID: 22228773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: Galpha(i2), a possible molecular marker for parasympathetic responsiveness.
    Welzig CM; Shin DG; Park HJ; Kim YJ; Saul JP; Galper JB
    Circulation; 2003 Dec; 108(22):2743-6. PubMed ID: 14623802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guggulipid use in hyperlipidemia: case report and review of the literature.
    Sahni S; Hepfinger CA; Sauer KA
    Am J Health Syst Pharm; 2005 Aug; 62(16):1690-2. PubMed ID: 16085931
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of low-density-lipoprotein lowering with statins.
    Rosenson RS; Stein JH
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comment from the cardiologic viewpoint].
    Lüscher TF
    Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
    [No Abstract]   [Full Text] [Related]  

  • 8. Dementia and statins.
    Kast RE
    Lancet; 2001 Mar; 357(9259):881. PubMed ID: 11265974
    [No Abstract]   [Full Text] [Related]  

  • 9. hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation.
    Ansell BJ; Watson KE; Weiss RE; Fonarow GC
    Heart Dis; 2003; 5(1):2-7. PubMed ID: 12549983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study.
    Farnier M; Steinmetz A; Retterstøl K; Császár A
    Clin Ther; 2011 Jan; 33(1):1-12. PubMed ID: 21397769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the PBS guidelines for lipid-lowering treatment appropriate for patients with CHD?
    Tallis GA
    Med J Aust; 1992 Aug; 157(4):283. PubMed ID: 1435453
    [No Abstract]   [Full Text] [Related]  

  • 12. Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study.
    Ghayour-Mobarhan M; Lamb DJ; Vaidya N; Livingstone C; Wang T; Ferns GA
    Angiology; 2005; 56(1):61-8. PubMed ID: 15678257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid lowering efficacy between morning and evening simvastatin treatment: a randomized double-blind study.
    Tharavanij T; Wongtanakarn S; Lerdvuthisopon N; Teeraaunkul S; Youngsriphithak P; Sritipsukho P
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S109-13. PubMed ID: 21294404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study.
    Santos AF; Keitel E; Bittar AE; Neumann J; Fuchs FD; Goldani JC; Fonseca NA; Prates VC; Zaffan D; Voegeli C; Kroth L; Steffenello G; Saitovitch D; Garcia VD
    Transplant Proc; 2001; 33(1-2):1194-5. PubMed ID: 11267254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dyslipidemia in diabetes mellitus: statins treatment raises survival of patients].
    Shestakova MV
    Ter Arkh; 1999; 71(1):67-9. PubMed ID: 10097307
    [No Abstract]   [Full Text] [Related]  

  • 16. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome.
    Bener A; Dogan M; Barakat L; Al-Hamaq AO
    J Prim Care Community Health; 2014 Jul; 5(3):180-7. PubMed ID: 24522932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.
    Adkins JC; Faulds D
    Drugs; 1997 Oct; 54(4):615-33. PubMed ID: 9339964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
    [No Abstract]   [Full Text] [Related]  

  • 20. A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia.
    Shafiq N; Bhasin B; Pattanaik S; Pandhi P; Venkateshan SP; Singh M; Malhotra S
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):548-55. PubMed ID: 17966840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.